Clinical Trial Details
EORTC-62092-22092-STBSG-ROG
Back to Clinical Trials Database
A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with Retroperitoneal sarcomas (RPS) - STRASS
Study documentation Publications
| Trial Status | Closed to Patient Entry |
|---|---|
| Dates |
Date of activation: 16-Jan-2012 Date Step1 close: 11-Apr-2017 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 256 - All Groups: 256 |
| Treatment |
Radiotherapy, Surgery |
| Study Staff |
Sylvie Bonvalot (Study Coordinator) , Institut Curie, Paris Rick Haas (Study Coordinator) , The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam Stephanie Kromar (Regulatory Affairs Manager) stephanie.kromar (at) eortc.org, EORTC Headquarters, Brussels Saskia Litiere (Statistician) saskia.litiere (at) eortc.org, EORTC Headquarters, Brussels Sandrine Marreaud (Clinical Research Physician) sandrine.marreaud (at) eortc.org, EORTC Headquarters, Brussels Axelle Nzokirantevye (Data Manager) axelle.nzokirantevye (at) eortc.org, EORTC Headquarters, Brussels Sandrine Rivrain (Pharmacovigilance Manager) sandrine.rivrain (at) eortc.org, EORTC Headquarters, Brussels Lucia Senna (Clinical Trial Assistant) lucia.senna (at) eortc.org, EORTC Headquarters, Brussels Ionela Stanciu (Junior Clinical Operations Manager) ionela.stanciu (at) eortc.org, EORTC Headquarters, Brussels Luca Vanderkam (Pharmacovigilance Manager) luca.vanderkam (at) eortc.org, EORTC Headquarters, Brussels Tina Verschuere (Senior Clinical Operations Manager) tina.verschuere (at) eortc.org, EORTC Headquarters, Brussels |
| Type of cancer | Soft Tissue and Bone Sarcoma |
| Participating groups |
EORTC Radiation Oncology Group EORTC Soft Tissue and Bone Sarcoma Group |
| Recruiting centers |
Centre Antoine Lacassagne (Nice, France) Centre Hospitalier de l'Université de Montreal - Hopital Notre-Dame (Montreal, Canada) Centre Leon Berard (Lyon, France) Centro Di Riferimento Oncologico (Aviano, Italy) Dana-Farber Cancer Institute & Harvard Medical School (Boston, United States of America) Fondazione IRCCS Istituto Nazionale dei Tumori (Milano, Italy) Gustave Roussy (Villejuif, France) Herlev Hospital - University Copenhagen (Herlev, Denmark) Hospital Universitario San Carlos (Madrid, Spain) Institut Bergonie (Bordeaux, France) Institut Curie (Paris, France) Institut Jules Bordet-Hopital Universitaire ULB (Brussels, Belgium) Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole - Institut Claudius Regaud (Toulouse, France) Istituto Clinico Humanitas (Rozzano, Milano, Italy) Istituto Oncologico Veneto IRCCS (Padova, Italy) Karolinska University Hospital, location Solna (Stockholm, Sweden) Klinikum der Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany) Leeds Teaching Hospitals NHS Trust - St. James's University Hospital (Leeds, United Kingdom) Leiden University Medical Centre (Leiden, Netherlands) Maria Sklodowska-Curie Memorial Cancer Centre (Warsaw, Poland) Mount Sinai Hospital (Toronto, Ontario, Canada) Newcastle Hospitals NHS Trust - Freeman Hospital, Northern Centre For Cancer Care (Newcastle upon Tyne, United Kingdom) Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom) Oslo University Hospital - Radiumhospitalet (Oslo, Norway) Radboud University Medical Center Nijmegen (Nijmegen, Netherlands) Royal Marsden Hospital - Chelsea, London (London, United Kingdom) Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital (Sheffield, United Kingdom) Technische Universitaet Muenchen - Klinikum Rechts Der Isar (Muenchen, Germany) The Christie NHS Foundation Trust (Manchester, United Kingdom) The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands) UHB-Queen Elisabeth Medical Centre (Birmingham, United Kingdom) UniversitaetsMedizin Mannheim (Mannheim, Germany) Universitaetsklinikum Koeln (Koeln, Germany) University College Hospital (London, United Kingdom) University Hospitals Bristol NHS Foundation Trust - Bristol Haematology And Oncology Centre (Bristol, United Kingdom) University Medical Center Groningen (Groningen, Netherlands) Vall d'Hebron Institut d’Oncologia (Barcelona, Spain) Western General Hospital (Edinburgh, United Kingdom) |
| Centers to be activated |
Institut régional du Cancer Montpellier (Montpellier, France) Istituto Europeo di Oncologia (Milano, Italy) Royal Free Hospital (London, United Kingdom) U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium) Universitaetsklinikum - Essen (Essen, Germany) |
| Protocol summary | http://clinicaltrials.gov/ct/show/NCT01344018 |
| NCT number | NCT01344018 |